Simplex Trading
GH icon

Simplex Trading’s Guardant Health GH Stock Holding History

Simplex Trading’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.12M Sell
14,100
-200
-1% -$21.8K ﹤0.01% 1991
2026
Q1 		$1.32M Sell
14,300
-13,000
-48% -$1.31M ﹤0.01% 2208
2025
Q4 		$2.79M Sell
27,300
-56,800
-68% -$5.08M ﹤0.01% 1712
2025
Q3 		$5.25M Sell
84,100
-2,600
-3% -$141K ﹤0.01% 1419
2025
Q2 		$4.51M Sell
86,700
-25,100
-22% -$1.12M ﹤0.01% 1435
2025
Q1 		$4.76M Buy
111,800
+15,800
+16% +$682K ﹤0.01% 1337
2024
Q4 		$2.93M Buy
96,000
+48,000
+100% +$1.35M ﹤0.01% 1869
2024
Q3 		$1.1M Sell
48,000
-11,700
-20% -$331K ﹤0.01% 2845
2024
Q2 		$1.72M Sell
59,700
-46,000
-44% -$1.07M ﹤0.01% 2348
2024
Q1 		$2.18M Buy
105,700
+83,600
+378% +$1.79M ﹤0.01% 2320
2023
Q4 		$597K Sell
22,100
-6,800
-24% -$178K ﹤0.01% 3506
2023
Q3 		$856K Sell
28,900
-500
-2% -$17.6K ﹤0.01% 2829
2023
Q2 		$1.05M Sell
29,400
-76,000
-72% -$2.18M ﹤0.01% 2547
2023
Q1 		$2.47M Sell
105,400
-111,600
-51% -$3.19M ﹤0.01% 1771
2022
Q4 		$5.9M Buy
217,000
+143,600
+196% +$6.57M 0.01% 1129
2022
Q3 		$3.95M Sell
73,400
-44,500
-38% -$2.28M ﹤0.01% 1370
2022
Q2 		$4.76M Buy
117,900
+61,100
+108% +$3.03M 0.01% 1177
2022
Q1 		$3.76M Buy
56,800
+18,600
+49% +$1.27M ﹤0.01% 1492
2021
Q4 		$3.82M Buy
38,200
+26,700
+232% +$2.76M ﹤0.01% 1428
2021
Q3 		$1.46M Hold
11,500
– – ﹤0.01% 2575
2021
Q2 		$1.43M Buy
11,500
+11,442
+19,728% +$1.54M ﹤0.01% 2630
2021
Q1 		$885K Sell
58
-120
-67% -$18.1K ﹤0.01% 2561
2020
Q4 		$2.29M Sell
178
-261
-59% -$30K ﹤0.01% 1640
2020
Q3 		$4.91M Buy
439
+300
+216% +$27.4K 0.01% 882
2020
Q2 		$1.13M Sell
139
-190
-58% -$15.3K ﹤0.01% 2030
2020
Q1 		$2.29M Sell
329
-24
-7% -$1.84K ﹤0.01% 1184
2019
Q4 		$2.76M Buy
353
+102
+41% +$7.35K 0.01% 1215
2019
Q3 		$1.6M Buy
251
+38
+18% +$3.35K ﹤0.01% 1518
2019
Q2 		$1.84M Buy
213
+186
+689% +$14.2K 0.01% 1365
2019
Q1 		$207K Buy
+27
New +$1.5K ﹤0.01% 3572

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Simplex Trading's GH Position: Q2 2026 in Review

Simplex Trading opened a new position in Guardant Health (GH) in Q2 2026: 3,056 shares worth $458K. The stake represents ﹤0.01% of the portfolio and ranks #3712 among its holdings. This is a return to the name: Simplex Trading previously reported a position in GH as recently as Q4 2025.

Simplex Trading first reported a position in GH in Q1 2019 and has held it in 16 quarters since. The position peaked at $4M in Q3 2022. 598 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Simplex Trading held 3,056 shares of Guardant Health worth $458K as of Q2 2026.
  • Guardant Health was a new Simplex Trading position in Q2 2026.
  • Guardant Health made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #3712 holding.
  • Simplex Trading first reported a position in Guardant Health in Q1 2019 and has held it in 16 quarters since.
  • Simplex Trading's Guardant Health position peaked at $4M in Q3 2022.
  • 598 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.